Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 1;314(4):R623-R628.
doi: 10.1152/ajpregu.00426.2017. Epub 2018 Jan 24.

Novel regulator of vasopressin secretion: phoenixin

Affiliations

Novel regulator of vasopressin secretion: phoenixin

Silvia Gasparini et al. Am J Physiol Regul Integr Comp Physiol. .

Abstract

The newly described hypothalamic peptide, phoenixin, is produced in the hypothalamus and adenohypophysis, where it acts to control reproductive hormone secretion. Both phoenixin and its receptor GPR173 are expressed in the hypothalamic supraoptic (SON) and paraventricular (PVN) nuclei, suggesting additional, nonreproductive effects of the peptide to control vasopressin (AVP) or oxytocin (OT) secretion. Hypothalamo-neurohypophysial explants released AVP but not OT in response to phoenixin. Intracerebroventricular administration of phoenixin into conscious, unrestrained male and female rats significantly increased circulating AVP, but not OT, levels in plasma, and it increased immediate early gene expression in the supraoptic nuclei of male rats. Bath application of phoenixin in hypothalamic slice preparations resulted in depolarization of PVN neurons, indicating a direct, neural action of phoenixin in the hypothalamus. Our results suggest that the newly described, hypothalamic peptide phoenixin, in addition to its effects on hypothalamic and pituitary mechanisms controlling reproduction, may contribute to the physiological mechanisms regulating fluid and electrolyte homeostasis.

Keywords: electrophysiology; hypothalamus; oxytocin; phoenixin; radioimmunoassay; vasopressin.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Vasopressin (AVP) and oxytocin (OT) release from hypothalamo-neurohypophysial explants in response to 100 nM phoenixin-20 amide, expressed as picogram of peptides released per 20-min incubation period (means ± SE; group sizes: n = 9). *P < 0.05 vs. preincubation period, paired Student’s t-test. ***P < 0.001 vs. preincubation.
Fig. 2.
Fig. 2.
Phoenixin (PNX) depolarizes magnocellular (MNC) paraventricular nucleus (PVN) neurons. A: representative current-clamp recordings from two MNC PVN neurons in slice preparation showing that bath application of 10 nM PNX (horizontal gray bar) caused a depolarization of the membrane potential. Both neurons returned to the baseline membrane potential (dashed line) following washout of PNX. B: range of responses of all MNC PVN neurons (n = 16) elicited by bath application of 10 nM PNX. The horizontal black bars represent the mean change in membrane potential ± SE, while each individual point represents the response of a single MNC neuron. Mean depolarization, 7.1 ± 0.9 mV.
Fig. 3.
Fig. 3.
Lateral ventricle administration of 3.0 nmol of phoenixin-20 amide, but not saline vehicle, resulted in early gene activation, as mirrored by c-Fos immunoreactivity, in cells of the supraoptic nucleus. A: supraoptic nucleus. A, inset: lack of staining in saline-injected control. B: paraventricular nucleus.
Fig. 4.
Fig. 4.
Time- and dose-dependent effect of phoenixin-20 amide on plasma vasopressin (AVP; A) and oxytocin (OT; B) levels in conscious male rats. Hormone levels are expressed as picograms of peptide per milliliter plasma (means ± SE; group sizes are indicated within the bars). *P < 0.05, **P < 0.01 vs. 3.0 nmol of phoenixin-20 dose, ANOVA (time and treatment) with Scheffé’s multiple-comparison testing.

References

    1. Samson WK. Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. Neuroendocrinology 40: 277–279, 1985. doi:10.1159/000124085. - DOI - PubMed
    1. Samson WK, Aguila MC, Martinovic J, Antunes-Rodrigues J, Norris M. Hypothalamic action of atrial natriuretic factor to inhibit vasopressin secretion. Peptides 8: 449–454, 1987. doi:10.1016/0196-9781(87)90008-8. - DOI - PubMed
    1. Samson WK, Lumpkin MD, McCann SM. Evidence for a physiological role for oxytocin in the control of prolactin secretion. Endocrinology 119: 554–560, 1986. doi:10.1210/endo-119-2-554. - DOI - PubMed
    1. Samson WK, McDonald JK, Lumpkin MD. Naloxone-induced dissociation of oxytocin and prolactin releases. Neuroendocrinology 40: 68–79, 1985. doi:10.1159/000124053. - DOI - PubMed
    1. Samson WK, Murphy TC. Adrenomedullin inhibits salt appetite. Endocrinology 138: 613–616, 1997. doi:10.1210/endo.138.2.4943. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources